Thomas Roth

3.3k total citations
57 papers, 2.8k citations indexed

About

Thomas Roth is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Thomas Roth has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Thomas Roth's work include Metal complexes synthesis and properties (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Cellular transport and secretion (5 papers). Thomas Roth is often cited by papers focused on Metal complexes synthesis and properties (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Cellular transport and secretion (5 papers). Thomas Roth collaborates with scholars based in United States, Germany and Switzerland. Thomas Roth's co-authors include Michael P. Woodward, Christopher J. Michejda, Robert W. Buckheit, Stephen H. Hughes, Marshall Morningstar, Heinz H. Fiebig, Paul L. Boyer, Felix Kratz, John L. Daiss and Clemens Unger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Thomas Roth

55 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Roth United States 31 1.1k 727 469 241 229 57 2.8k
Silvia N.J. Moreno United States 39 1.9k 1.7× 623 0.9× 234 0.5× 241 1.0× 63 0.3× 82 4.4k
Gary E. Means United States 23 2.1k 1.9× 393 0.5× 265 0.6× 380 1.6× 114 0.5× 55 3.5k
Alex F. Drake United Kingdom 32 1.7k 1.5× 522 0.7× 216 0.5× 154 0.6× 331 1.4× 115 3.2k
Paweł Grochulski Canada 22 2.7k 2.4× 310 0.4× 208 0.4× 293 1.2× 116 0.5× 75 3.6k
Lee Whitmore United Kingdom 13 3.5k 3.1× 325 0.4× 278 0.6× 344 1.4× 410 1.8× 21 5.3k
Maarten R. Egmond Netherlands 42 3.6k 3.2× 824 1.1× 328 0.7× 427 1.8× 222 1.0× 137 5.5k
Chhitar M. Gupta India 32 1.4k 1.3× 299 0.4× 198 0.4× 233 1.0× 215 0.9× 155 3.1k
Enríque Pérez‐Payá Spain 41 3.3k 2.9× 525 0.7× 313 0.7× 309 1.3× 791 3.5× 151 5.3k
Keith Rose Switzerland 31 2.2k 1.9× 637 0.9× 365 0.8× 159 0.7× 57 0.2× 98 3.3k
V. Kostka Czechia 20 1.3k 1.1× 174 0.2× 284 0.6× 189 0.8× 175 0.8× 79 2.0k

Countries citing papers authored by Thomas Roth

Since Specialization
Citations

This map shows the geographic impact of Thomas Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Roth more than expected).

Fields of papers citing papers by Thomas Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Roth. The network helps show where Thomas Roth may publish in the future.

Co-authorship network of co-authors of Thomas Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Roth. A scholar is included among the top collaborators of Thomas Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Roth. Thomas Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hecht, Markus, Thomas Harrer, Hartwig Klinker, et al.. (2015). Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells. PLoS ONE. 10(6). e0130277–e0130277. 44 indexed citations
2.
Roth, Thomas, et al.. (2012). Suitability of ultrasound assisted extraction for chromatographic determination of selected flame retardants used in styrenic polymers. Eurasian Journal of Analytical Chemistry. 7(2). 67–77. 1 indexed citations
3.
Roth, Thomas, Martha Kaeslin, Manfred Heller, et al.. (2010). Identification of bracovirus particle proteins and analysis of their transcript levels at the stage of virion formation. Journal of General Virology. 91(10). 2610–2619. 36 indexed citations
4.
Vincent, Bruno, Martha Kaeslin, Thomas Roth, et al.. (2010). The venom composition of the parasitic wasp Chelonus inanitus resolved by combined expressed sequence tags analysis and proteomic approach. BMC Genomics. 11(1). 693–693. 92 indexed citations
5.
Kaeslin, Martha, et al.. (2009). Venom of the egg-larval parasitoid Chelonus inanitus is a complex mixture and has multiple biological effects. Journal of Insect Physiology. 56(7). 686–694. 26 indexed citations
6.
Clauß, Marcus, et al.. (2008). Comparative digestion studies in wild suids at Rotterdam Zoo. Zoo Biology. 27(4). 305–319. 14 indexed citations
7.
Rodrigues, Paula, Thomas Roth, Heinz H. Fiebig, et al.. (2006). Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. Bioorganic & Medicinal Chemistry. 14(12). 4110–4117. 27 indexed citations
8.
Barthelmes, Hans, Ellen Niederberger, Thomas Roth, et al.. (2001). Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells. British Journal of Cancer. 85(10). 1585–1591. 42 indexed citations
10.
Rodrigues, Paula, Ulrich Beyer, Peter Schumacher, et al.. (1999). Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorganic & Medicinal Chemistry. 7(11). 2517–2524. 92 indexed citations
11.
Kratz, Felix, Ulrich Beyer, Thomas Roth, et al.. (1998). Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||. Journal of Pharmaceutical Sciences. 87(3). 338–346. 139 indexed citations
12.
Kratz, Felix, et al.. (1998). Albumin Conjugates of the Anticancer Drug Chlorambucil: Synthesis, Characterization, andIn Vitro Efficacy. Archiv der Pharmazie. 331(2). 47–53. 35 indexed citations
13.
Roth, Thomas, et al.. (1995). Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.. PubMed. 10(8). 655–66. 4 indexed citations
14.
Passaniti, Antonino & Thomas Roth. (1989). Coated vesicles from chicken liver bind ferritin. Journal of Cell Science. 92(2). 187–196. 3 indexed citations
15.
Woods, John & Thomas Roth. (1980). Selective protein transport: Identity of the solubilized phosvitin receptor from chicken oocytes. Journal of Supramolecular Structure. 14(4). 473–481. 7 indexed citations
16.
Woods, John & Thomas Roth. (1979). Selective protein transport: Characterization and solubilization of the phosvitin receptor from chicken oocytes. Journal of Supramolecular Structure. 12(4). 491–504. 8 indexed citations
18.
Greef, J. De, W.L. Butler, Thomas Roth, & Henri Frédéricq. (1971). Control of Senescence in Marchantia by Phytochrome. PLANT PHYSIOLOGY. 48(4). 407–412. 26 indexed citations
19.
Greef, J. De, W.L. Butler, & Thomas Roth. (1971). Greening of Etiolated Bean Leaves in Far Red Light. PLANT PHYSIOLOGY. 47(4). 457–464. 72 indexed citations
20.
Roth, Thomas & L. Gerald Parchman. (1967). Diplotene Achiasmatic Chromosomes Following Normal Synapsis at Pachynema. Proceedings annual meeting Electron Microscopy Society of America. 25. 86–87. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026